Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Ching Chang

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
International Journal of Colorectal Disease|December 4, 2024
Combining moderate dosage of Bevacizumab with TAS-102 provides longer progression-free time in refractory metastatic colorectal CancerKuan-Yu Tseng, Mu-Ying Yang, Wei-Shone Chen, et al.
Scientific Reports|July 29, 2021
Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spreadHung-Chih Hsu, Kuo-Cheng Huang, Wei-Shone Chen, et al.
International Journal of Cancer|January 28, 2016
Clinical significance of circulating plasma DNA in gastric cancerWen-Liang Fang, Yuan-Tzu Lan, Kuo-Hung Huang, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 23, 2024
The survival outcome differs between left-sided colon cancer and middle/low rectal cancer after colorectal hepatic metastasectomyJin-Han Yang, Wen-Ling Lin, Wei-Shone Chen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 17, 2020
Effect of Primary Tumor Location on Postmetastasectomy Survival in Patients with Colorectal Cancer Liver MetastasisTien-Hua Chen, Wei-Shone Chen, Jeng-Kai Jiang, et al.
Clinical Colorectal Cancer|April 25, 2023
Anti-VEGF Therapy Possibly Extends Survival in Patients With Colorectal Brain Metastasis by Protecting Patients From Neurologic DisabilityChih-Wen Chen, Tao-Shen Ou, Wei-Shone Chen, et al.
Nutrients|July 14, 2023
Efficacy and Safety of a Parenteral Nutrition Program for Patients with <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching StudyYu-Tang Chang, Chou-Chen Chen, Shih-Ching Chang, et al.
American Journal of Cancer Research|January 8, 2024
Survival benefit of metastasectomy in first-line cetuximab therapy in patients with RAS wild-type metastatic colorectal cancer: a nationwide registryChou-Chen Chen, Shih-Ching Chang, Yu-Yao Chang, et al.
Journal of the Chinese Medical Association : JCMA|June 9, 2023
Surgical strategy for colorectal cancer with synchronous liver and extrahepatic metastases: A scoring system and decision tree modelChan-Wei Tseng, Hao-Wei Teng, Chun-Chi Lin, et al.
American Journal of Cancer Research|January 13, 2025
Outcomes of upfront primary tumor resection in patients with synchronous <i>RAS</i> wild-type metastatic colorectal cancerPo-Jung Chen, Chou-Chen Chen, Shih-Ching Chang, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
International Journal of Colorectal Disease|December 4, 2024
Combining moderate dosage of Bevacizumab with TAS-102 provides longer progression-free time in refractory metastatic colorectal CancerKuan-Yu Tseng, Mu-Ying Yang, Wei-Shone Chen, et al.
Scientific Reports|July 29, 2021
Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spreadHung-Chih Hsu, Kuo-Cheng Huang, Wei-Shone Chen, et al.
International Journal of Cancer|January 28, 2016
Clinical significance of circulating plasma DNA in gastric cancerWen-Liang Fang, Yuan-Tzu Lan, Kuo-Hung Huang, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 23, 2024
The survival outcome differs between left-sided colon cancer and middle/low rectal cancer after colorectal hepatic metastasectomyJin-Han Yang, Wen-Ling Lin, Wei-Shone Chen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 17, 2020
Effect of Primary Tumor Location on Postmetastasectomy Survival in Patients with Colorectal Cancer Liver MetastasisTien-Hua Chen, Wei-Shone Chen, Jeng-Kai Jiang, et al.
Clinical Colorectal Cancer|April 25, 2023
Anti-VEGF Therapy Possibly Extends Survival in Patients With Colorectal Brain Metastasis by Protecting Patients From Neurologic DisabilityChih-Wen Chen, Tao-Shen Ou, Wei-Shone Chen, et al.
Nutrients|July 14, 2023
Efficacy and Safety of a Parenteral Nutrition Program for Patients with <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching StudyYu-Tang Chang, Chou-Chen Chen, Shih-Ching Chang, et al.
American Journal of Cancer Research|January 8, 2024
Survival benefit of metastasectomy in first-line cetuximab therapy in patients with RAS wild-type metastatic colorectal cancer: a nationwide registryChou-Chen Chen, Shih-Ching Chang, Yu-Yao Chang, et al.
Journal of the Chinese Medical Association : JCMA|June 9, 2023
Surgical strategy for colorectal cancer with synchronous liver and extrahepatic metastases: A scoring system and decision tree modelChan-Wei Tseng, Hao-Wei Teng, Chun-Chi Lin, et al.
American Journal of Cancer Research|January 13, 2025
Outcomes of upfront primary tumor resection in patients with synchronous <i>RAS</i> wild-type metastatic colorectal cancerPo-Jung Chen, Chou-Chen Chen, Shih-Ching Chang, et al.
Pageof 16